Omalizumab in severe allergic asthma

10th May 2013 by Louise Hudman

This guideline advises that Omalizumab can be used in the treatment of asthma. It is a monoclonal antibody that binds to IgE and is given every 2 to 4 weeks subcut. We may start seeing patients treated with this, so worth knowing about it. Treatment is to be started and maintained by specialists only. Quite a lot of criteria must be met before use, so it’ll only be used in the most severe asthma, where allergy testing has been positive.

Read for free

Sign up to access everything.

Three-month free trial

Login

Already a member? Login to view this content.

Login

"My accountant husband said that invoicing on LocumDeck was very impressive. Incredibly easy to use and intuitive – excellent piece of work."

Dr Daphne Hazel

Dr Daphne Hazel

See the full list of features within our NASGP membership plans

Membership